Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3236 Target Snapshot

Tyrosine-protein phosphatase non-receptor type 12 · SINGLE PROTEIN · Homo sapiens

132Compounds
18Assays
0Approved Drugs
136.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q05209. Use UniProt Q05209 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q05209 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tyrosine-protein phosphatase non-receptor type 12 as ChEMBL target CHEMBL3236, mapped to UniProt Q05209. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tyrosine-protein phosphatase non-receptor type 12
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3236
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q05209
Tyrosine-protein phosphatase non-receptor type 12
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tyrosine-protein phosphatase non-receptor type 12 is the right protein anchor across sources, using UniProt Q05209 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTyrosine-protein phosphatase non-receptor type 12
UniProt AccessionQ05209
Component TypeProtein
Sequence Length780 aa

Tyrosine-protein phosphatase non-receptor type 12

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tyrosine-protein phosphatase non-receptor type 12, mapped to UniProt Q05209. Sequence length is 780 aa.

Mapped IDQ05209
Review nameTyrosine-protein phosphatase non-receptor type 12
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50135.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4750435 6.89 IC50 130.0 Preclinical
CHEMBL1408081 6.67 IC50 216.0 Preclinical
CHEMBL1407368 6.5 IC50 313.0 Preclinical
CHEMBL1701224 6.49 IC50 325.0 Preclinical
CHEMBL1320181 6.33 IC50 471.0 Preclinical
CHEMBL1390354 6.15 IC50 714.0 Preclinical
CHEMBL2396718 6.1 IC50 800.0 Preclinical
CHEMBL1572439 6.04 IC50 916.0 Preclinical
CHEMBL1704862 6.02 IC50 953.0 Preclinical
CHEMBL601167 6.01 IC50 975.0 Preclinical
Distribution

pChEMBL Value Distribution

19
5.0
20
5.5
10
6.0
3
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

18
Total Assays
64
Tested Compounds
3
Assay Types
Binding — 13 assays, 32 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 9 13 5.2
assay format 2 10 4.6
cell-based format 2 9 4.7
ADME — 4 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 1 5.5
assay format 1 0
Functional — 1 assays, 64 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 64 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine